APA (7th ed.) Citation

Campbell, G. A., Barrett, S. E., Thakral, S., Lowinger, M., Faassen, F., Vander Kamp, K. A., . . . Snyder, P. (2025). A pharmaceutical industry survey results on the cycle time, drivers and enablers, for key deliverables in the early phase of drug product development from dose limiting toxicity to first subject first dose: The survey conducted by the IQ cycle time benchmarking working group. Journal of drug delivery science and technology, 108, 106888. https://doi.org/10.1016/j.jddst.2025.106888

Chicago Style (17th ed.) Citation

Campbell, Gossett A., et al. "A Pharmaceutical Industry Survey Results on the Cycle Time, Drivers and Enablers, for Key Deliverables in the Early Phase of Drug Product Development from Dose Limiting Toxicity to First Subject First Dose: The Survey Conducted by the IQ Cycle Time Benchmarking Working Group." Journal of Drug Delivery Science and Technology 108 (2025): 106888. https://doi.org/10.1016/j.jddst.2025.106888.

MLA (9th ed.) Citation

Campbell, Gossett A., et al. "A Pharmaceutical Industry Survey Results on the Cycle Time, Drivers and Enablers, for Key Deliverables in the Early Phase of Drug Product Development from Dose Limiting Toxicity to First Subject First Dose: The Survey Conducted by the IQ Cycle Time Benchmarking Working Group." Journal of Drug Delivery Science and Technology, vol. 108, 2025, p. 106888, https://doi.org/10.1016/j.jddst.2025.106888.